UNSPSC 85702914: Revision of external fixation device in left tibia, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of external fixation device in left tibia, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QWHX5Z

UNSPSC 85702914, Revision of external fixation device in left tibia, external approach (Commodity), shows limited concrete activity aligned with its nominal clinical scope. Recent state and local opportunities tagged to this code do not involve orthopedic device revision or surgical implant services; instead, they span occupational health surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, and surgical benefit carve-out programs. The code does not appear to capture state and local procurement of orthopedic surgical implants, device revision procedures, or related surgical hardware and supplies in current solicitation activity.

The issuing bodies in the recent-opportunity block span state departments, county health systems, municipal pension boards, and county commissioners offices across Arizona, California, Washington, and Texas. The Washington State Department of Transportation sought occupational medical surveillance services with a pre-bid conference and cost-based evaluation (RFP20260825, due October 9, 2026); the City of Phoenix Retirement Office solicited independent medical evaluation and disability record summarization for pension benefit determinations (RTMRFP26001, due October 16, 2026); the City of Long Beach requested proposals for a surgical procedure carve-out benefit program covering knee, hip, orthopedic, shoulder, spine, heart, weight loss, and oncology procedures through Centers of Excellence (HR26753, due October 7, 2026); and Collier County sought pharmacy benefit management services covering approximately 2,400 employees with historical annual pharmacy spending of $8.7 million (RFP 25-8414, closed April 9, 2026). The code shows no recent state and local contract opportunities for orthopedic surgical devices, implants, or device revision procedures as nominally defined.